Epigenetic biotech raises bumper round to the Tune of $175M to fund entry into clinic
Fecha de publicación:
13/01/2025
Fuente:FierceBiotech
Investors clearly appreciate the song that Tune Therapeutics is singing, handing over $175 million in series B funds as the biotech takes its epigenetic silencing drug into the clinic.